| 1 |
32259555 | Drug interaction study of flavonoids toward OATP1B1 and their 3D structure activity relationship analysis for predicting hepatoprotective effects. | 2020 May 15 |
3 |
| 2 |
30652318 | Functional characterization for polymorphic organic anion transporting polypeptides (OATP/SLCO1B1, 1B3, 2B1) of monkeys recombinantly expressed with various OATP probes. | 2019 Feb |
1 |
| 3 |
23738582 | Clarithromycin substantially increases steady-state bosentan exposure in healthy volunteers. | 2014 Jan |
1 |
| 4 |
24842639 | CYP2C9, SLCO1B1, SLCO1B3, and ABCB11 polymorphisms in patients with bosentan-induced liver toxicity. | 2014 Jun |
1 |
| 5 |
23387445 | Phase I and II metabolism and MRP2-mediated export of bosentan in a MDCKII-OATP1B1-CYP3A4-UGT1A1-MRP2 quadruple-transfected cell line. | 2013 May |
2 |
| 6 |
17251982 | Inhibitory and inductive effects of rifampin on the pharmacokinetics of bosentan in healthy subjects. | 2007 Mar |
2 |
| 7 |
17496208 | Bosentan is a substrate of human OATP1B1 and OATP1B3: inhibition of hepatic uptake as the common mechanism of its interactions with cyclosporin A, rifampicin, and sildenafil. | 2007 Aug |
1 |